Related Experiment Video

Updated: Aug 22, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Using microarrays to predict resistance to chemotherapy in cancer patients

Chung-Hae Lee1, Pascale F Macgregor

  • 1Microarray Centre, Clinical Genomics Centre, University Health Network, Canadian Breast Cancer Research Alliance, 790 Bay Street, Ste. 1000, Toronto, ON, M5G 1NB, Canada.

Pharmacogenomics
|September 1, 2004
PubMed

Insights

Microarray technology offers new ways to study chemotherapy resistance in cancer. This approach aims to identify new drug targets and advance personalized medicine for better patient outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Biotechnology

Background:

  • Chemotherapy resistance is a significant challenge in cancer treatment, impacting patient outcomes.
  • Whole genome strategies, particularly DNA microarrays, are revolutionizing cancer research.
  • Microarray technology holds promise for identifying novel therapeutic targets and understanding cancer biology.

Purpose of the Study:

  • To explore the application of microarray technology in studying anticancer drug resistance.
  • To discuss strategies for translating laboratory findings into clinical practice.
  • To provide an overview of microarray techniques and their role in personalized medicine.

Main Methods:

  • Review of microarray technology, including array comparative genomic hybridization and promoter arrays.
  • Analysis of recent microarray studies focused on cancer drug resistance.
  • Discussion of the integration of genomic data into clinical settings.

Main Results:

  • Microarray studies are providing initial insights into the mechanisms of drug resistance.
  • The technology facilitates the identification of potential biomarkers for treatment response.
  • Advancements in microarray analysis contribute to a deeper understanding of cancer heterogeneity.

Conclusions:

  • Microarray technology is a powerful tool for dissecting cancer drug resistance.
  • Further research using microarrays can accelerate the development of personalized cancer therapies.
  • Translating microarray findings to the clinic is crucial for improving cancer patient survival rates.

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...